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Abstract: Relapse of acute lymphoblastic leukemia (ALL) is dangerous and it worsens the prognosis
of patients; however, prognostic markers or therapeutic targets for ALL remain unknown. In the
present study, using databases such as TARGET, GSE60926 and GSE28460, we determined that KIF2C
and its binding partner, KIF18B are overexpressed in patients with relapsed ALL compared to that
in patients diagnosed with ALL for the first time. As 50% of the residues are exactly the same
and the signature domain of KIF2C is highly conserved between human and zebrafish, we used
zebrafish embryos as a model to investigate the function of kif2c in vivo. We determined that kif2c
is necessary for lymphopoiesis in zebrafish embryos. Additionally, we observed that kif2c is not
related to differentiation of HSCs; however, it is important for the maintenance of HSCs as it provides
survival signals to HSCs. These results imply that the ALL relapse-related gene KIF2C is linked to the
survival of HSCs. In conclusion, we suggest that KIF2C can serve as a novel therapeutic target for
relapsed ALL.
Keywords: KIF2C; TARGET; GEO; ALL; zebrafish; hematopoiesis
1. Introduction
Acute lymphoblastic leukemia (ALL) is a common type of blood cancer, which presents a high
number of undifferentiated lymphoid cells in the peripheral blood and bone marrow [1]. The symptoms
of ALL include fever, fatigue and bleeding or enlargement of lymph nodes; ALL generally occurs in
children aged 2–5 years [2,3]. ALL treatment includes chemotherapy, radiation therapy, biological
therapy or immunotherapy; however, there is a chance of relapse in certain patients [4–6].
Approximately 20% of young patients with ALL suffer from a relapse and their prognosis is
very poor [7,8]. The ratio of relapse is enhanced by a short duration of the first remission, bone
marrow involvement, age greater than 10 years, unfavorable cytogenetics or Down syndrome [9–11].
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Despite many attempts to study the genetic factors involved in the relapse of ALL, significant genetic
factors remain unknown.
KIF2C is a member of the kinesin-like protein family and this protein family can bind to the
microtubules to transport organelles and segregate chromosomes during cell division. According to
recent studies, KIF2C is also involved in DNA repair [12,13]. As KIF2C is important for segregation of
chromosomes and transport of organelles, many studies suggest that KIF2C functions as an oncogene in
many solid tumors [14]. KIF2C forms a complex with KIF18B, which plays a major role in microtubule
plus-end depolymerizing activity in mitotic cells. The primary function of KIF18B may be to transport
KIF2C along the microtubules [15,16]. However, there has been limited research on the role of KIF2C
and its relationship to KIF18B in leukemia.
Since the hematological processes and lineages of zebrafish and humans are evolutionally
conserved in vertebrates, many researchers have used zebrafish as an in vivo model for studies on
hematopoiesis [17–20]. Among them, Park et al. investigated the function of the leukemia-related gene
cobll1 using zebrafish embryos and reported that it is important for blast formation in chronic myeloid
leukemia [18]. Because zebrafish embryos are transparent, whole-mount in situ hybridization (WISH)
is mainly used for the observation of target gene expression in zebrafish embryos. Additionally, gene
knockdown studies, which are important for investigating the function of genes, can be performed
easily via administering morpholino injection in zebrafish [18,21].
In the present study, we conducted various experiments to evaluate the recurrence of B-precursor
ALL (B-ALL). The following datasets were analyzed to confirm the expression of KIF2C in patients with
ALL—pediatric ALL-Phase II (TARGET, 2018), TARGET_paired sample consisting of data from only
paired samples extracted from the TARGET cohort, GSE60926 and GSE28460. In addition, the differences
in KIF2C expression between samples from first-diagnosed and relapsed patients were statistically
analyzed and the correlation between KIF2C and KIF18B was confirmed. Subsequently, the function of
kif2c was evaluated using zebrafish embryos.
2. Results
2.1. KIF2C Expression Is Up-Regulated in Relapse Samples
As shown in Table 1, no statistical differences were observed between TARGET, TARGET_paired
sample and GSE60926 in terms of gender, age, mixed-lineage leukemia (MLL) status or race. The t-test
indicated that the KIF2C expression level in the relapse sample was significantly higher than that in the
first-diagnosis sample in all cohorts (p-values: 1.977 × 10−4 in GSE28460, 8.945 × 10−5 in GSE60926,
1.497 × 10−5 in TARGET_paired sample and 1.232 × 10−11 in TARGET-ALL, Figure 1).
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2.3. kif2c Expression is Reduced by Morpholino Injection in Zebrafish Embryos  
According to the Ensemble database, the amino acid sequence of KIF2C is highly conserved 
between humans and zebrafish. Alignment between human KIF2C and zebrafish kif2c shows 50% of 
the residues to be exactly same, 15% structural similarity in the residues and 10% of gaps in 
compositional matrix adjustment (Figure S2). As KIF2C is important for the segregation of 
chromosomes during mitosis, the tubulin-binding site and the nucleotide-binding site are considered 
signature domains of KIF2C. We confirmed that these two sites are highly conserved between 
humans and zebrafish, indicating that zebrafish can function as a good in vivo model to investigate 
the functions of KIF2C (Figure S2). For the knockdown of kif2c in zebrafish, we used splice-blocking 
morpholino. To optimize the dosage of morpholino, we injected 2.5 ng, 5 ng and 10 ng of kif2c-
Figure 1. Differences in expression levels of KIF2C. Comparison of KIF2C expression levels in
(A) TARGET, (B) TARGET_paired, (C) GSE60926, and (D) GSE28460 (**** indicates significance at
p value < 0.0001, *** indic tes significance at p value < 0.001).
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(Paired Sample) GSE60926 GSE28460
Diagnosis Relapse p Value Diagnosis Relapse p Value Diagnosis Relapse p Value Diagnosis Relapse p Value
(n = 134) (n = 116) (n = 76) (n = 76) (n = 22) (n = 20) (n = 49) (n = 49)
Sex
Male 74 (55.2) 64 (55.2) 1 42 (55.3) 42 (55.3) 1 15 (68.2) 14 (70.0) 0.878 / / /
Female 60 (44.8) 52 (44.8) 1 34 (44.7) 34 (44.7) 1 6 (27.3) 5 (25.0) 0.75 / / /
Age
<10 79 (59.0) 69 (59.5) 0.963 44 (57.9) 44 (57.9) 1 16 (72.7) 14 (70.0) 0.821 / / /
≥10 55 (41.0) 47 (40.5) 0.955 32 (42.1) 32 (42.1) 1 6 (27.3) 6 (30.0) 0.721 / / /
MLL Status
Positive 6 (4.5) 4 (3.4) 0.695 3 (3.9) 3 (3.9) 1 / / / / / /
Negative 105 (78.4) 86 (74.1) 0.121 58 (76.3) 58 (76.3) 1 / / / / / /
Unknown 23 (17.2) 26 (22.4) 0.683 15 (19.7) 15 (19.7) 1 / / / / / /
Race
White 94 (70.1) 81 (69.8) 0.979 54 (71.1) 54 (71.1) 1 / / / / / /
Asian 4 (3.0) 2 (1.7) 0.548 2 (2.6) 2 (2.6) 1 / / / / / /
Black or African American 15 (11.2) 16 (13.8) 0.603 9 (11.8) 9 (11.8) 1 / / / / / /
Etc. 21 (15.7) 17 (14.7) 0.856 11 (14.5) 11 (14.5) 1 / / / / / /
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2.2. KIF2C and KIF18B Are Positively Correlated before and after Relapse
Since KIF18B forms a complex with KIF2C, the difference in the expression level of KIF18B was
analyzed in each B-ALL cohort. Similar to KIF2C, KIF18B was increased in relapsed samples compared
to diagnosis in all cohorts (Figure 2). Next, Spearman correlation analysis was performed to investigate
the correlation between KIF2C and KIF18B. As a result, all cohorts showed a strong correlation with a
correlation coefficient of 0.7 or higher regardless of the diagnosis time and recurrence time (Figure S1).
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Comparison of KIF18B expression levels in (A) TARGET, (B) TARGET_paired sample, (C) GSE60926 and
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ns e ns that there is no significant difference .
2.3. kif2c Expression is Reduced by Morpholino Injection in Zebrafish Embryos
According to the Ensemble database, the amino acid sequence of KIF2C is highly conserved
between humans and zebrafish. Alignment between human KIF2C and zebrafish kif2c shows 50% of the
residues to be exactly same, 15% structural similarity in the residues and 10% of gaps in compositional
matrix adjustment (Figure S2). As KIF2C is important for the segregation of chromosomes during
mitosis, the tubulin-binding site and the nucleotide-binding site are considered signature domains
of KIF2C. We confirmed that these two sites are highly conserved between humans and zebrafish,
indicating that zebrafish can function as a good in vivo model to investigate the functions of KIF2C
(Figure S2). For the knockdown of kif2c in zebrafish, we used splice-blocking morpholino. To optimize
the dosage of morpholino, we injected 2.5 ng, 5 ng and 10 ng of kif2c-targeting morpholino at the 1-cell
stage of the zebrafish embryos. Further, the mRNA expression of kif2c-targeting morpholino-injected
embryos was compared with that of the control embryos. We observed that embryos injected with
10 ng of morpholino showed reduced expression of kif2c, which was less than 50% compared to that in
control embryos, according to RT-PCR analysis (Figure 3A). Next, the efficiency of the knock-down was
confirmed by quantitative RT-PCR (qRT-PCR). Similar to the results from RT-PCR, the expression of
kif2c showed an approximately 50% reduction, according to qRT-PCR (Figure 3B). These data suggest
that 10 ng of morpholino is required for kif2c knockdown in zebrafish embryos.
Int. J. Mol. Sci. 2020, 21, 3127 5 of 12
Int. J. Mol. Sci. 2019, 20, x FOR PEER REVIEW 5 of 12 
 
targeting morpholino at the 1-cell stage of the zebrafish embryos. Further, the mRNA expression of 
kif2c-targeting morpholino-injected embryos was compared with that of the control embryos. We 
observed that embryos injected with 10 ng of morpholino showed reduced expression of kif2c, which 
was less than 50% compared to that in control embryos, according to RT-PCR analysis (Figure 3A). 
Next, the efficiency of the knock-down was confirmed by quantitative RT-PCR (qRT-PCR). Similar 
to the results from RT-PCR, the expression of kif2c showed an approximately 50% reduction, 
according to qRT-PCR (Figure 3B). These data suggest that 10 ng of morpholino is required for kif2c 
knockdown in zebrafish embryos.  
Figure 3. Expression of kif2c in zebrafish embryos is reduced by morpholino injection. (A) RT-PCR 
analysis of kif2c and β-actin using zebrafish embryos at 4 days post fertilization (dpf). Total RNA was 
isolated from uninjected embryos and kif2c-targeting morpholino-injected embryos (2.5 ng, 5 ng and 
10 ng). Relative expression of kif2c is quantified using ImageJ. (B) Quantitative RT-PCR analysis of 
kif2c. Relative mRNA expression of kif2c is compared between uninjected control embryos and kif2c-
targeting morpholino injected embryos. (*** indicates significance at p value <0.001) 
2.4. Lymphopoiesis is Reduced in kif2c-Morphants 
We found that kif2c expression was higher in patients with relapsed B-ALL than in patients 
diagnosed with B-ALL for the first time (Figure 1). Similarly, we focused on elucidating the function 
of kif2c in hematopoiesis, especially in lymphopoiesis. The recombination activating gene (rag) is 
usually used as a lymphocyte-specific marker. Therefore, after knockdown of kif2c, the lymphocyte 
markers rag1 and rag2 were analyzed using WISH and qPCR. Compared to the control embryos, kif2c-
morphants showed reduced rag1-positive signal in the thymus of the zebrafish embryos (Figure 4A). 
A qPCR assay demonstrated that the relative mRNA expression of rag1 and rag2 was reduced in kif2c-
morphants (Figure 4B). These data suggest that kif2c is important for lymphopoiesis.  
 
Figure 4. kif2c is linked to the development of lymphocytes in zebrafish embryos. (A) Whole-mount 
in situ hybridization of uninjected embryos and kif2c-targeting morpholino-injected embryos at 4 days 
Figure 3. Expres ion of kif2c in zebrafish embryos is reduced by morpholino injection. (A) RT-PCR
analysis of kif2c and β-actin using zebrafish embryos at 4 days post fertilization (dpf). Total RNA was
isolated from uninjected embryos and kif2c-targeting morpholino-injected embryos (2.5 ng, 5 ng and
10 ng). Relative xpression of kif2c is quantified using ImageJ. (B) Quantit tive RT-PCR analysis of k f2c.
Relative mRNA expression of k f2c is compared betw en uninj cted control embry s and kif2c-target ng
morpholino injected embryos. (*** indicates s gn ficance at p v lu < 0.001).
2.4. Lymphopoiesis Is Reduced in kif2c-Morphants
We found that kif2c expression was higher in patients with relapsed B-ALL than in patients
diagnosed with B-ALL for the first time (Figure 1). Similarly, we focused on elucidating the function of
kif2c in hematopoiesis, especially in lymphopoiesis. The recombination activating gene (rag) is usually
used as a lymphocyte-specific marker. Therefore, after knockdown of kif2c, the lymphocyte markers
rag1 and rag2 were analyzed using WISH and qPCR. Compared to the control embryos, kif2c-morphants
showed reduced rag1-positive signal in the thymus of the zebrafish embryos (Figure 4A). A qPCR assay
demonstrated that the relative mRNA expression of rag1 and rag2 was reduced in kif2c-morphants
(Figure 4B). These data suggest that kif2c is important for lymphopoiesis.
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Figure 4. kif2c is linked to the development of lymphocytes in zebrafish embryos. (A) Whole-mount in
situ hybrid zat on of uninjecte mbryos and kif2c-targeting morpholino-injected embryos at 4 days
po t fertilization (dpf) using the lymphocyte marker rag1. Black arrows indicate th signal of rag1 at
thymus. (B) qRT-PCR analysis of rag1 and rag2 expression in uninjected embryos and kif2c-targeting
morpholino-injected embryos at 4 dpf. The expression of mRNA is normalized to that of β-actin mRNA
levels (*** indicates significance at p value < 0.001, * indicates significance at p value < 0.05).
2.5. kif2c Is Necessary for Maintenance of Hematopoietic Stem Cells
In the normal process of lymphopoiesis, hematopoietic stem cells (HSCs) are preferentially
differentiated from endothelial cells of the dorsal aorta. During differentiation, HSCs show runx1
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expression at 28 h post fertilization (hpf) [22]. After differentiation, HSCs move to the caudal
hematopoietic tissue (CHT) for expansion and these HSCs express cmyb [23]. Thereafter, some of the
HSCs are transported to the thymus for differentiation into lymphocytes [24].
As the lymphocytes were reduced in kif2c-morphants, we checked the stages of lymphopoiesis in
kif2c-morphants to determine which stage of lymphopoeisis was inhibited. First, differentiation of
HSCs was checked in the dorsal aorta using an HSC-specific probe, runx1, at 28 hpf. Similar to the
control embryos, kif2c-morphants showed a normal signal of runx1 in the dorsal aorta (Figure 5A),
suggesting that kif2c is not related to the differentiation of HSCs at initial stages. Further, HSCs at
the CHT were checked using another HSC-specific probe, cmyb, at 72 hpf. In the normal process of
hematopoiesis, cmyb-positive cells should expand in the CHT but kif2c-morphants showed a reduction
in the number of cmyb-positive cells in the CHT (Figure 5B). These data suggest that kif2c is important
for the maintenance of HSCs in CHT.
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2.6. kif2c Is Important for Survival of Hematopoietic Stem Cells 
To investigate the cause of reduction in HSCs in the CHT, we examined cell proliferation and 
apoptosis in kif2c-morphants. Cell proliferation in embryos was evaluated using the 5-ethynyl-
2’deoxyuridine (EdU) assay at 3 dpf. Similar to that observed in normal embryos, the number of EdU-
positive cells was not altered in the CHT of kif2c-morphants (Figure 6A), which indicates that cell 
Figure 5. kif2c is related to the maintenance of hematopoietic stem cells. (A) Whole-mount in
situ hybridization of uninjected embryos and kif2c-targeting morpholino-injected embryos at 28 hpf
using runx1 probe. Black arrows indicate the signal of runx1 at dorsal aorta. (B) Whole-mount in
situ hybridization uninjected embryos and kif2c-targeting morpholino-injected embryos at 3 days
post fertilization (dpf) using cmyb probe. Black arrows indicate the signal of cmyb at caudal
hematopoietic tissue.
2.6. kif2c Is Important for Survival of Hematopoietic Stem Cells
To investigate the cause of reduction in HSCs in the CHT, we examined cell proliferation
and apoptosis in kif2c-morphants. Cell proliferation in embryos was evaluated usi g the
5-ethynyl-2’deoxyuridi e (EdU) assay at 3 dpf. Similar to that observed in normal embryos, t e number
f EdU-positive cell w s not altered in the CHT of kif2c-morphants (Figure 6A), which indicates
that ll proliferation is not related to reduced HSCs in the CHT. Next, acridine orang (AO) staining
was used to detect apoptosis. Compared to the control embryos, the number of AO-positive cells
was highly increased in the CHT of kif2c-morphants (Figure 6B), indicating that induced apoptosis
is responsible for the reduction of HSCs in the CHT of kif2c-morphants. Since p53 is a key molecule
inducing apoptosis [25], the expression of p53 was analyzed to validate the apoptosis induced in
kif2c-morphants at 3 dpf. As AO-stained cells were increased in kif2c-morphants, the expression of p53
was also increased in the CHT (Figure 6C). These data suggest that kif2c plays a role in the maintenance
of HSCs by improving their survival.
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3. Discussion
Relapse of ALL is dangerous and critical for the prognosis of patients; however, appropriate
therapeutic target genes for ALL are not known. In the present study, through large data analysis,
we found that KIF2C is significantly increased in relapsed B-ALL patients as compared to that in
patients diagnosed with B-ALL for the first time. Additionally, it was confirmed that KIF2C and KIF18B
showed high correlation before and after relapse. Next, using zebrafish embryos, we revealed that
kif2c plays an important role in the maintenance of HSCs by improving their survival.
Various studies have suggested that KIF2C is important in solid tumors. TMA abdel-Fatah et al.
suggested that KIF2C is a novel prognostic marker in breast cancer [26]. Gnjatic et al. reported that
NY-CO-58/KIF2C is overexpressed in several solid tumors and that it induces frequent T cell response
in colorectal cancer patients [27]. Gan et al. observed that KIF2C plays an oncogenic role in non-small
cell lung cancer and that it can be negatively regulated by miR325-3p [13]. Although many studies
show that KIF2C is an oncogenic factor in various solid tumors, we demonstrated for the first time that
KIF2C plays an oncogenic role in leukemia.
KIF18B is known to play a role in the transport of KIF2C using the microtubules in complex with
KIF2C [15,16]. On the basis of this information, we analyzed the correlation between KIF2C and KIF18B
before and after relapse to determine if KIF18B shows the same tendency to increase as KIF2C. As a
result, the strong correlation between KIF2C and KIF18B was confirmed and it can be predicted that
the correlation between the two would play an important role in relapse.
We found that KIF2C is dramatically induced in relapsed B-ALL patients from different data
bases and the zebrafish paralog, kif2c is important for the maintenance of HSCs by improving survival.
Although leukemic hematopoiesis and normal hematopoiesis is different, our study suggests that KIF2C
can be a critical gene in the relapse of ALL. Until now, relapsed ALL is treated using chemotherapy,
radiotherapy or stem cell transplantation. Knowing that KIF2C is important in the relapse of ALL and
for the maintenance of HSCs in zebrafish, we propose that KIF2C can be a novel therapeutic target
Int. J. Mol. Sci. 2020, 21, 3127 8 of 12
for relapsed ALL. However, there are some limitations in this study. First, the lack of sufficient data
may affect the credibility of the results. Second, since we identified only mRNA levels from databases
and zebrafish experiments, it will be checked in protein level. Next, a more detailed study on the
specific mechanism by which KIF2C induces survival signals for HSCs is required, using KIF2C as a
therapeutic target for patients with ALL who suffer from relapse.
4. Materials and Methods
4.1. Patients
The gene expression data for pediatric B-cell ALL were downloaded from the cBioPortal for Cancer
Genomics (https://www.cbioportal.org/) for TARGET-ALL and NCBI (National Center for Biotechnology
Information) Gene Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/geo/) database for
GSE60926 and GSE28460 [28–32]. TARGET-ALL contributed to 1978 samples consisting of 134 diagnosis
and 116 relapse bone marrow samples. Within the TARGET-ALL dataset, we additionally secured data
representing the TARGET_paired sample cohort, which includes only paired samples; this dataset
consists of 77 diagnosis and 77 relapse paired bone marrow samples. GSE60926 contributed to a total
of 50 samples consisting of 22 diagnosis and 20 relapse bone marrow samples. GSE28460 contributed
to 98 samples consisting of 49 diagnoses and 49 relapse paired bone marrow samples. The patient
characteristics are described in Table 1.
4.2. Statistical Methods for Analyzing ALL Databases
The statistical differences in sex, age (<10 or≥10 years), MLL status (positive, negative or unknown)
and race (including White, Asian, Black or African American) were analyzed using the chi-square test.
KIF2C expression levels in the first-diagnosis and relapse samples were compared using a t-test based
on the statannot python package (statannot version 0.2.2 and python version 3.7.1, Python Software
Foundation, 2020). Next, to examine the correlation between KIF2C and KIF18B, spearman correlation
analysis was performed on the diagnosis samples and relapse samples of each cohort on the basis of
the SciPy python package (SciPy version 1.4.1, Python Software Foundation, 2020).
4.3. Zebrafish Maintenance and Morpholino Injection
Wild-type zebrafish AB was maintained in an automatic circulation system (Genomic-Design) at
28.5 ◦C. All experiments using zebrafish embryos were performed in accordance with the guidelines
of the Ulsan National Institute of Science and Technology (UNIST) Institutional Animal Care
and Use Committee (IACUC) (IACUC approval number—UNISTIACUC-15-14, date: 2016-10-11).
Zebrafish embryos were cultured using E3 solution in incubators at 28 ◦C. Splice-blocking morpholino
targeting kif2c (Gene Tools, Philomath, OR, USA) was dissolved in DEPC water at 25 ng/nL stock
solution. The sequence of kif2c-targeting morpholino is 5’-ACATTTAGTACAAACCTCTTTTCCT-3’.
Morpholino targeting kif2c was injected in the embryos of wild-type zebrafish AB at the 1-cell
stage of development. Microinjections were performed with a Femtojet 4i microinjector (Eppendorf,
Hamburg, Germany).
4.4. Quantitative RT-PCR
Total RNA was isolated from 30 homogenized zebrafish embryos using 1 mL of TRIzol reagent
(Molecular Research Center Inc., Cincinnati, OH, USA). Chloroform was added for protein separation
and isopropanol was added for the precipitation of RNA. Reverse transcription of 3 µg total RNA was
performed using SuperScriptF IV Reverse transcriptase (Thermo Fisher, Waltham, Massachusetts, MA,
USA). qRT-PCR analysis was performed using PowerUp SYBR green Master Mix (Thermo Fisher).
Expression of target genes was analyzed by the comparative threshold method and the results were
normalized to β-actin as an endogenous control gene. qRT-PCR data represents data obtained using
biological and technical triplicates.
Int. J. Mol. Sci. 2020, 21, 3127 9 of 12
4.5. Whole-Mount In Situ Hybridization
For WISH, the embryos were fixed using 4% paraformaldehyde in phosphate-buffered saline
(PBS) and dehydrated using methanol at −20 ◦C overnight. Samples were incubated with acetone at
−20 ◦C for 30–40 min. The samples were hybridized with a digoxigenin (DIG)-labeled antisense RNA
probe in a hybridization buffer (50% formamide, 5 × SSC, 500 µg/mL Torula yeast tRNA, 50 µg/mL
heparin, 0.1% Tween-20 and 9 mM citric acid (pH 6.5) for 3 days. The samples were then washed
using 2× and 0.2× SSC solutions. The washed samples were blocked with normal goat serum and
bovine serum albumin and incubated with alkaline phosphate-conjugated DIG antibodies (1:4000)
(Roche, Mannheim, Germany) overnight at 4 ◦C. The samples were then washed and incubated
with alkaline phosphatase reaction buffer [100 mM Tris (pH 9.5), 50 mM MgCl2, 100 mM NaCl and
0.1% Tween-20] and Alkaline phosphatase detection kit (NBT (p-nitroblue tetrazolium chloride)/BCIP
(5-bromo-4-chloro-3-indolyl phosphate)) (Promega) for visualization of the WISH signal.
4.6. Acridine Orange Staining of Zebrafish Embryos
Zebrafish embryos were incubated with 50 µg/mL of AO solution in a dark environment for 1 h at
room temperature. After 1 h, the zebrafish embryos were washed thrice with E3 buffer, anesthetized
using tricaine and observed under a confocal microscope (LSM880, Carl Zeiss, Jena, Germany).
4.7. 5-Ethynyl-2’deoxyuridine Assay
Zebrafish embryos were saturated in 10 mM EdU in E3 buffer with 15% DMSO for 10 min.
The embryos were fixed using 4% paraformaldehyde in PBS. The fixed embryos were dehydrated in
methanol at −20 ◦C. Next, the embryos were rehydrated in PBS with 0.1% Tween-20 and penetrated
with 1% Triton X-100 for 1 h at room temperature. The EdU signal was detected using the Click-iTEdU
Alexa Fluor 488 Imaging Kit (Invitrogen) and the samples were imaged using an LSM880 confocal
microscope (Carl Zeiss).
4.8. Statistical Analysis in Zebrafish Experiments
Statistical analysis was performed using Student’s t-test. All experiments were performed in
triplicates. Figures and graphs show the average of three independent experiments. The error
bars indicate the standard error of the mean (SEM). A p-value less than 0.05 was considered
statistically significant.
5. Conclusions
The main purpose of our study was to strengthen the foundation of precision medicine by
analyzing large genome data. There is a growing need to discover novel therapeutic target genes for
relapsed ALL. We analyzed the ability of KIF2C to serve as a therapeutic target of relapsed ALL and
confirmed that KIF2C is highly induced in relapsed ALL patients; kif2c plays an important role in the
homeostasis of HSCs through improvement of their survival. Based on our study, we propose that
KIF2C is a novel therapeutic target of relapsed ALL.
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Dpf Days post fertilization
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